MB PATHOLOGY LTD

Company number 14253877 · Insolvent (In Administration)

MB PATHOLOGY LTD is a private limited company registered in LONDON, United Kingdom, incorporated on 25 Jul 2022. Its registered activity is general medical practice activities. The company entered insolvency. Its latest published accounts for the period ending 29 Jul 2023 show equity of £100. It has filed 1 set of accounts, 1 of them after the deadline.

Company details

Company number
14253877 · official register
Status
In Administration
Legal form
Private Limited Company
Incorporated
25 Jul 2022
Registered address
EC2A 4AA LONDON
Postcode area
London East Central
Activity
86210 General medical practice activities
Industry
Human health activities

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
29 Jul 202315 Oct 2024– –£100– –––

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in London East Central

Questions about MB PATHOLOGY LTD

What is the company number of MB PATHOLOGY LTD?

MB PATHOLOGY LTD is registered under company number 14253877 in the official register of United Kingdom. View it at the official register.

Is MB PATHOLOGY LTD still active?

No. MB PATHOLOGY LTD is insolvent.

Has MB PATHOLOGY LTD gone bankrupt or into insolvency?

Yes. MB PATHOLOGY LTD entered insolvency.

When was MB PATHOLOGY LTD founded?

MB PATHOLOGY LTD was incorporated on 25 Jul 2022.

Where is MB PATHOLOGY LTD registered?

MB PATHOLOGY LTD's registered address is in EC2A 4AA LONDON (London East Central), United Kingdom.

What do the latest accounts of MB PATHOLOGY LTD show?

The latest published accounts (period ending 29 Jul 2023) show equity of £100.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 9 Nov 2026.